Drug Shortage Report for TEMODAL
| Report ID | 153500 |
| Drug Identification Number | 02241096 |
| Brand name | TEMODAL |
| Common or Proper name | temozolomide capsules |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMOZOLOMIDE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 5CAP SACHET |
| ATC code | L01AX |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-02-18 |
| Actual start date | 2022-02-17 |
| Estimated end date | 2022-03-04 |
| Actual end date | 2022-03-04 |
| Shortage status | Resolved |
| Updated date | 2022-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-03-05 | English | Compare |
| v8 | 2022-03-04 | French | Compare |
| v7 | 2022-03-04 | English | Compare |
| v6 | 2022-02-18 | English | Compare |
| v5 | 2022-02-17 | French | Compare |
| v4 | 2022-02-17 | English | Compare |
| v3 | 2022-01-26 | French | Compare |
| v2 | 2022-01-26 | English | Compare |
| v1 | 2022-01-26 | English | Compare |
Showing 1 to 9 of 9